Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1B/2 Study Of Liposomal Annamycin (L-Annamycin) In Subjects With Previously Treated Soft-Tissue Sarcomas With Pulmonary Metastases

X
Trial Profile

Phase 1B/2 Study Of Liposomal Annamycin (L-Annamycin) In Subjects With Previously Treated Soft-Tissue Sarcomas With Pulmonary Metastases

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 31 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Annamycin (Primary)
  • Indications Cancer metastases; Soft tissue sarcoma
  • Focus Adverse reactions
  • Acronyms STS Lung Mets
  • Sponsors Moleculin Biotech
  • Most Recent Events

    • 24 Jan 2024 According to a Moleculin Biotech media release, final MB-107 data readout will be in 2H 2024. the company will Identify next phase of development/pivotal program and in Late 2024 into 1H 202, it will Initiate 1st line STS study with an investigator-initiated trial.
    • 24 Jan 2024 Results presented in a Moleculin Biotech Media Release.
    • 13 Nov 2023 Interim results presented in a Moleculin Biotech Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top